Increase in hospital stay duration and prevalence of chronic diseases is expected to drive the demand for global hospital acquired infection control market in the forecast period.
According to TechSci Research report, “Global Hospital Acquired Infection Control Market By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Others) By Application (Disease Testing, Drug-Resistance Testing) By Technology (Phenotypic Methods, Genotypic Methods) By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others) By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others) By Company, By Region, Forecast & Opportunities, 2026”, the global hospital acquired infection control market is expected to witness steady growth for the next five years. Hospital acquired infection are generally caused due to presence of pathogens who spread quickly in the human body and affect the health system adversely.
Infections are treated either by following a proper diet and routine or by taking antibiotics and by encouraging the natural healing process. Presence of unhygienic conditions inside and outside of healthcare facilities in addition with adoption of improper sterilization techniques in healthcare centers is aiding in increasing the growth of the hospital acquired infection control market across the globe. Rising disposable income among the consumers is boosting the expenditure capacity for availing healthcare facilities. Economic development of developing economies and presence of large population suffering with different diseases is considered a major driver for the growth of the market in the forecast period.
High-end investments by the government to develop the healthcare facilities is increasing the adoption rate of medical devices thereby fueling the market growth for the predicted period. Surge in demand of medical devices which are capable of disinfecting for example endoscope reprocessing device is influencing the growth of the market. Technological evolutions enhancing the safety of patients and can prevent cross contaminations among patients are gaining high demand from healthcare industry. Virulence of microbial agents, immunity power of patients and environmental factors such as infected materials are some other prominent factors fueling the market. Government initiatives to prevent the infection and ensure high degree of infection prevention are releasing the set of precautionary measures and guidelines and also promotion for efficient disease prevention which is expected to accelerate the growth of the hospital acquired infection control market.
However, off label use of antibiotic drugs along with growth of microbial resistance which may create hindrance in the global hospital acquired infection control market growth.
Browse XX Figures spread through XX Pages and an in-depth TOC on "Global Hospital Acquired Infection Control Market”.
Global hospital acquired infection control market is segmented into product, application, technology, disease, end user, region, and company. Based on product, market is further divided into sterilizers, disinfectors, endoscope reprocessors and others. Disinfector segment is expected to account for major market share for the forecast period, 2022-2026. Disinfectors are further classified into hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants/ disinfectant robots. High demand from consumers for different applications is aiding to huge market share over the predicted period. Disinfection is a process of removal of all pathogenic microorganisms which is achieved by use of liquid chemicals or by the process of wet pasteurization.
Based on end user, market is categorized into hospitals, ICUs, ambulatory surgical, diagnostic centers, nursing homes, maternity centers among others. Hospitals followed closely by ICUs segment is expected to dominate the hospital acquired infection control market. Based on technology, hospital segment is bifurcated into phenotypic methods and genotypic methods. Phenotypic methods are further classified into colorimetric methods, nitrate reductase assay and phage-based assays. Genotypic methods are sub-segmented into solid-phase hybridization techniques, DNA sequencing, polymerase chain reaction (PCR) techniques and microarrays.
Becton, Dickinson and Company, Steris Corporation Ltd., Advanced Sterilization Products, Getinge Group, Kimberly-Clark Corporation, Cantel Medical Corporation, BioMérieux SA, Belimed AG, 3M company, Sterigenics International LLC, Synergy Health PLC, Olympus Corporation Ltd, Danaher Corporation Ltd. (Cepheid), Crosstex International, Inc., Diversey Inc are the leading players operating in global hospital acquired infection control market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several hospitals acquired infection control equipment manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7617
Customers can also request for 10% free customization on this report.
“Prevailing condition of pandemic which requires strict control over hospital acquired control along with high-end investments by major market players for development of technology such as gas plasma sterilization process for expansion of hospital acquired infection control market is aiding to increase market growth. High prevalence of HAI and poor training and infection control practices, poor healthcare infrastructure and lack of awareness are some of the other prominent factors which are anticipated to propel the market growth until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Hospital Acquired Infection Control Market By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Others) By Application (Disease Testing, Drug-Resistance Testing) By Technology (Phenotypic Methods, Genotypic Methods) By Disease (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, UTI, Others) By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of global hospital acquired infection control market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of global hospital acquired infection control market.
Browse Related Reports:
Global Veterinary Immunodiagnostics Market By Product Type (Analyzers, Consumables) By Animal Type (Livestock (Cattle, Pigs, Poultry, Others), Companion (Feline, Equine, Canine, Others) By Technology (ELISA, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Colorimetric Immunoassay), Radioimmunoassay, Rapid Tests, Others) By Application (Infectious Disease, Autoimmune Disorder, Endocrinology, Oncology, Bone and Mineral Diseases, Others) By End User (Reference Laboratories, Academic and Research Institutes, Veterinary Hospitals & Clinics, Point of care/In-house testing) By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores and E-Commerce) By Region, Competition Forecast & Opportunities, 2026
India Coronavirus Vaccine Market By Infection Type (SARS-CoV, MERS-CoV, SARS-CoV-2) By Vaccine Type (Virus vaccine, Viral vector vaccine, Nucleic acid vaccines, Protein based vaccine, Others) By Product Type (Monovalent Vaccine v/s Multivariant Vaccine) By Route of Administration (Oral, Intramuscular, Intranasal) By Patient Type (Pediatric v/s Adult) By End User (Hospitals, Clinics, Research Institutes, Others) By Region, Competition Forecast & Opportunities, FY2027
Mr. Ken Mathews
708 Third Avenue,
New York – 10017
Email: [email protected]
For More Market Research Blogs Visit: https://techsciblog.com/